Sézary's Disease
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma (NCT04234048) | SciTech Development, Inc. | 2023-12-18 |
Track Sézary's Disease automatically
Every clearance here is in the API, with alerts when new ones post.